ArticleMovement disorders : official journal of the Movement Disorder Society2022
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations.
Abstract read
In one paragraph
Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.CNS neuroscience & therapeutics · 2023Pooled it
- Natural history and 12-month progression of multiple system atrophy in a Chinese cohort.BMC neurology · 2026Observational
- Heart rate variability provides prognostic value in multiple system atrophy.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026Article
- Multiple System Atrophy Combined Outcome Assessment (MuSyCA): process, format, and validation plan.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026Article
- Clinical and neuroimaging correlates of disease related gait patterns in patients with multiple system atrophy cerebellar type.Scientific reports · 2025Article
- Early onset sleep disorders predict severity, progression and death in multiple system atrophy.Journal of neurology · 2025Article
- Peripheral Inflammation Profile of Cerebellar Ataxia.Current neuropharmacology · 2025Article
- Clinical comparison of the 2008 and 2022 diagnostic criteria for early multiple system atrophy-cerebellar type.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2024Article
- Recent Advances in Clinical Trials in Multiple System Atrophy.Current neurology and neuroscience reports · 2024Review
- Article
- Time-resolved quantification of fine hand movements as a proxy for evaluating bradykinesia-induced motor dysfunction.Scientific reports · 2024Article
- Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?Brain sciences · 2024Article
- Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023Article
- Tackling the usefulness of neurofilament light chain in multiple system atrophy: diagnostic and prognostic perspectives.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023Article
- Neurofilament Light Chain in Spinal Fluid and Plasma in Multiple System Atrophy - A Prospective, Longitudinal Biomarker Study.Research square · 2023Article
- UMSARS Versus Laryngoscopy-Based Assessment of Dysphagia.Movement disorders clinical practice · 2023Article
- Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS).Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023Review
- Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers.Frontiers in neurology · 2023Review
- Responsiveness of UMSARS and other clinical measures in a longitudinal structured care clinic for multiple system atrophy.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2022Article
- Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study.BMC medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Florian KrismerDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-4493-5073
Jose-Alberto PalmaDepartment of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
Giovanna Calandra-BuonauraDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Iva StankovicNeurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Beograd, Serbia.ORCID 0000-0003-1484-4717
Luca VignatelliDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.ORCID 0000-0002-9051-7091
Anna-Karin BergerClinical Science, Assessment and Innovation, Department of Clinical Development, Lundbeck, Valby, Denmark.
Cristian Falup-PecurariuDepartment of Neurology, County Clinic Hospital, Faculty of Medicine, Transylvania University, Brasov, Romania.
Alexandra Foubert-SamierCHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, Bordeaux, France.
Günter HöglingerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID 0000-0001-7587-6187
Horacio KaufmannDepartment of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
Larry KellermanPatient Advocacy Group, Multiple System Atrophy Coalition, McLean, Virginia, USA.
Han-Joon KimDepartment of Neurology and Movement Disorder Center, Seoul National University Hospital, Seoul, South Korea.ORCID 0000-0001-8219-9663
Thomas KlockgetherDepartment of Neurology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0001-6174-5442
Johannes LevinGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Pablo Martinez-MartinCenter for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain.
Tiago A MestreParkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-6973-7479
Maria Teresa PellecchiaDepartment of Medicine, Surgery and Dentistry, Neuroscience Section, University of Salerno, Salerno, Italy.ORCID 0000-0002-6217-313X
Susan PerlmanDepartment of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Irfan QureshiPharmaceutical Company, Biohaven Pharmaceuticals, New Haven, Connecticut, USA.
Olivier RascolFrench Reference Center for MSA, CIC 1436, NS-Park/FCRIN network and NeuroToul COEN Center, University Hospital of Toulouse, University of Toulouse 3 and INSERM, Toulouse, France.ORCID 0000-0002-1410-6397
Anette SchragDepartment of Clinical Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.ORCID 0000-0002-9872-6680
Klaus SeppiDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0001-6503-1455
Huifang ShangDepartment of Neurology, Laboratory of Neurodegenerative Disorders, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Glenn T StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
Gregor K WenningDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Wolfgang SingerDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Wassilios G MeissnerCHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, Bordeaux, France.ORCID 0000-0003-2172-7527
Funding
Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic ApproachR01NS092625 · NINDS · MAYO CLINIC ROCHESTER · PI SINGER, WOLFGANG, VEMURI, PRASHANTHI · 2015 to 2025
$6.6MA futility trial of sirolimus in multiple system atrophyR01NS107596 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KAUFMANN, HORACIO, PALMA CARAZO, JOSE ALBERTO · 2018 to 2020
$2.4MNINDS NIH HHS R01 NS092625NINDS NIH HHS R01 NS107596
Abstract
PubMed holds no abstract for this paper.
Indexed as
Multiple System AtrophyDisability EvaluationHumansSeverity of Illness Index
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.